Cardiff, UK April 21-22, 2016
INDIGO (Investigation of Novel biomarkers and Definition of the role of the microbiome in Graves Orbitopathy) and EUGOGO (EUropean Group of Graves’ Orbitopathy) are coming together during April 2016 in Cardiff for the first joint symposium of the 2 groups.
The meeting is a rare opportunity to bring together an international panel of speakers from the thyroid autoimmunity and ophthalmology communities in addition to experts on the microbiome to discuss new concepts on the origins of Graves’ disease and orbitopathy.
The meeting has been endorsed by the British Thyroid Association.
Click here to download the provisional programme
Click here to register
Logo INDIGO - Testata web 2-01
- INDIGO is an EU Marie Sklodowska-Curie funded Industry Academia Partnerships & Pathways (IAPP) of 1.2M euros.
- It is coordinated by Cardiff University and includes academic partners in Essen and Milan plus SMEs in Italy and Wales.
- It has collaborators across Europe, many of them members of EUGOGO.
- INDIGOs main objective is to improve management of Graves’ orbitopathy (GO), a distressing eye condition which affects more than 3 million people in Europe.
The photo, from left to right Back : Daryn Michael, Giulia Masetti, Simona Palermo, Hedda Kohling, Utta Berchner-Pfannschmidt, Danila Covelli, Iveta Garaiova, Lei Zhang. Front : John Williams, Sue Plummer, Marian Ludgate, Mario Salvi, Anja Eckstein.